Stocks and Investing Stocks and Investing
Fri, September 22, 2017
[ 12:00 AM ] - WOPRAI
Brian Essex Maintained (ACN) at Hold with Increased Target to $140 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Larry Biegelsen Initiated (BDX) at Buy and Held Target at $225 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Do Kim Maintained (ALNY) at Buy with Increased Target to $134 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Yuriy Vlasov Downgraded (AA) to Hold on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Brandon Oglenski Upgraded (AAL) to Buy and Increased Target to $65 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Tim Anderson Upgraded (AZN) to Buy on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Howard Rubel Maintained (BA) at Strong Buy with Increased Target to $300 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Alethia Young Maintained (ASND) at Buy with Increased Target to $50 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Omotayo Okusanya Maintained (DOC) at Hold with Increased Target to $19 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Juan Sanabria Downgraded (VTR) to Hold on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Kenneth Wong Initiated (BLKB) at Strong Buy and Held Target at $100 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Richard Eastman Maintained (TRMB) at Buy with Increased Target to $44 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Tom Abrams Initiated (TRP) at Hold and Held Target at $53 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
David Steinberg Initiated (SVRA) at Strong Buy and Held Target at $20 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Fintan Ryan Initiated (SXT) at Strong Buy and Held Target at $88 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Kenneth Wong Initiated (TYL) at Strong Buy and Held Target at $200 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Ana Gupte Maintained (UHS) at Buy with Increased Target to $132 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Paul Newsome Upgraded (UFCS) to Strong Buy on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Tom Forte Initiated (YELP) at Strong Buy and Held Target at $51 on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Novid Rassouli Downgraded (X) to Sell on, Sep 22nd, 2017
[ 12:00 AM ] - WOPRAI
Ying Huang Maintained (BOLD) at Strong Buy with Increased Target to $33 on, Sep 22nd, 2017
Thu, September 21, 2017
[ 12:00 AM ] - WOPRAI
Nicole Deblase Downgraded (TEX) to Hold on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Rob Oliver Maintained (WK) at Hold with Increased Target to $20 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Ambrish Srivastava Maintained (TXN) at Buy with Increased Target to $105 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Benjamin Swinburne Maintained (BATRK) at Sell with Increased Target to $25 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Benjamin Swinburne Maintained (BATRA) at Sell with Increased Target to $25 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Paul Matteis Maintained (ALNY) at Hold with Increased Target to $112 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Alethia Young Maintained (ALNY) at Buy with Increased Target to $123 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
Alan Carr Maintained (ALNY) at Strong Buy with Increased Target to $125 on, Sep 21st, 2017
[ 12:00 AM ] - WOPRAI
David Lebovitz Maintained (ALNY) at Hold with Increased Target to $101 on, Sep 21st, 2017

David Lebovitz Maintained (ALNY) at Hold with Increased Target to $101 on, Sep 21st, 2017


Published on 2024-10-25 22:56:26 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $50 to $101 on, Sep 21st, 2017.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David

  • Christopher Marai of "Nomura" Initiated at Sell and Held Target at $56 on, Friday, September 15th, 2017
  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $99 on, Friday, September 8th, 2017
Contributing Sources